Video

Dr Shruti Agnihotri Highlights the Importance of Value-Based Neurologic Care for Post–COVID-19 Patients

Shruti Agnihotri, MD, associate professor at the University of Alabama Birmingham, discusses how value-based care can help patients who experience neurologic chronic disease states after COVID-19, in addition to patients with conditions like stroke and dementia.

Value-based care is important for patients who experience neurologic issues after COVID-19, as well as patients with stroke and dementia, says Shruti Agnihotri, MD, associate professor at the University of Alabama Birmingham.

Transcript

What role does value-based care play in neurological conditions?

Value-based care is very important in neurologic conditions—many different neurologic conditions, of course, in things like dementia, strokes—but I think it's also important in our post–COVID-19 patient population. At the heart of what we do so far for our post–COVID-19 patients is managing high blood pressure, diabetes; the chronic conditions, chronic states, which affect how the brain will function for these patients. I think, yes, there is a large role that value-based care or managed care can play in these patient care situations.

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Pierluigi Porcu, MD
Benjamin Chen, MD, PhD
Kimberly Westrich, MA, chief strategy officer, NPC
Erin Weber, MS
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Marla Black Morgan, MD, Phoebe Neurology Associates
Elizabeth Grush, MBA
Raj Chovatiya, MD, PhD, MSCI.
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo